VaDDC
  • About
    • Join VaDDC
    • Affiliated Organizations
  • Leadership
    • Executive committee members
  • Events
    • VirginiaCancerRx
    • VirginiaBrainRx
  • News
  • Partnerships
    • Industry Initiatives
    • Featured Collaborations
    • Become a Sponsor
Select Page
Targeted Nanoparticle Delivery of Paclitaxel

Targeted Nanoparticle Delivery of Paclitaxel

by Discovery | Nov 18, 2016 | Uncategorized

Virginia Tech scientists have developed a cancer drug that increases the effectiveness of a common chemotherapy treatment and dramatically reduces devastating side effects, such as hair loss, nausea, and nerve pain. The new drug uses gold nanoparticles created by the...

Recent Posts

  • Frank Gupton receives a $25M award from the Gates foundation
  • VirginiaCancerRx in the News!
  • Award-winning “intrapreneur” researcher Rob Gourdie launches Acomhal Research Inc.
  • Carlier & Slade receive grant to develop new malaria therapeutics
  • Inova Names Milton L. Brown, MD, PhD, Director of the New Inova Center for Drug Discovery and Development and Targeted Therapeutics

Archives

  • September 2017
  • June 2017
  • May 2017
  • February 2017
  • December 2016
  • November 2016
  • September 2016
  • July 2016
  • April 2015
  • Facebook
  • Twitter
  • RSS
© 2016 Virginia Drug Discovery Consortium